Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-049882

General Counsel bought 7,500 shares at $2.58 ($19,376)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patton Stephana Eilene General Counsel 2017-08-21 Purchase +7,500 $2.58 $19,376 7,500 D
Open-market purchases · 7,500 sh · avg $2.58 · $19,376
Loading xslF345X03/doc4.xml…